Health and Medical
-
Paramedic Training VR Nearly Doubles Students’ Understanding of Teamwork in Medicine. The Demonstration Test was Conducted for 663 Students at 14 Vocational Schools.
The effect of VR was Confirmed in In-Hospital Care by Paramedics as its Importance is Increasing under the Revised Paramedic Act Jolly Good Inc. (based in Chuo-ku, Tokyo, Japan; CEO: Kensuke...
-
WHO Goodwill Ambassador for Leprosy Elimination Recognized with WHO Director-General’s Award for Global Health at 75th World Health Assembly
Ambassador will call on countries to strengthen efforts against leprosy in meetings with delegations attending WHA TOKYO, May 22, 2022 - WHO Goodwill Ambassador for Leprosy Elimination Yohei Sasakawa arrives in...
-
“VR Hands-On Training” — Live-Action Clinical Training with Hand Tracking Selected as a Finalist for AWE Auggie Awards, the World’s Biggest VR/AR Awards!
Jolly Good Inc. (based in Chuo-ku, Tokyo, Japan; CEO: Kensuke Joji; hereafter “Jolly Good”), is pleased to announce that the latest version of “VR hands-on training”, live-action clinical training with hand...
-
English Version of Hands-On Medical VR Developed. Exhibiting At SXSW 2022.
World’s first live-action medical VR system featuring hand tracking allows for both training and evaluation TOKYO, March 9, 2022 — Jolly Good Inc. (based in Chuo-ku, Tokyo, Japan; CEO: Kensuke Joji;...
-
Over 500,000 sales in Japan in the pandemic (COVID-19) period The stress-free mask frame “MASKBONE”, supporting the center of non-woven mask with a single line, kicks off to sell globally
Takebayashi Manufacturing, a manufacturer of plastic molds in Osaka Japan since 1972 (CEO : Yoshitaka Takebayashi), has opened a global sales site for “MASKBONE” on 1st March that is a stress-free...
-
Notice of exclusive license agreement for artificially modified nucleic acid technology with Takeda Pharmaceutical Company Limited
Luxna Biotech Co., Ltd. and Takeda Pharmaceutical Company Limited announced that it has entered into an exclusive worldwide license agreement with Takeda Pharmaceutical Company Limited for the use of Luxna’s breakthrough...
-
CancerX announces 18 “Cancer Agenda,” which we aim to collectively impact for the society at World Cancer Week 2022.
To celebrate and promote World Cancer Day (February 4, 2022), CancerX hosted World Cancer Week 2022 from January 30 to February 5. This event involved 102 panelists, including experts and influencers...
-
New Business Partnership Between Otsuka Pharmaceutical and Digital Health VR Technology Developer Jolly Good
Agreement Worth Potentially 5 Billion Yen for the VR Healthcare Market First Step: Social Rehabilitation for Schizophrenia Sufferers TOKYO, Feb. 1, 2022 — With the aim of building a regional cooperative...
-
“Don’t forget leprosy” campaign gathers pace as World Leprosy Day approaches
Yohei Sasakawa, Chairman of The Nippon Foundation, has served as WHO Goodwill Ambassador for Leprosy Elimination since 2001. He is part of Sasakawa Leprosy (Hansen’s Disease) Initiative, which has organized the...
-
A Japanese mental-healthcare app, “Awarefy,” is now available in English
This app allows you to effortlessly experience “Self-care of Mind and Heart” born from the Zen-inspired Japanese culture. A Japanese startup Hakali Inc., based in Tokyo, Japan (CEO: Shinichiro Ogawa), has...